Automatable algorithms to identify nonmedical opioid use using electronic data: a systematic review

Objective Improved methods to identify nonmedical opioid use can help direct health care resources to individuals who need them. Automated algorithms that use large databases of electronic health care claims or records for surveillance are a potential means to achieve this goal. In this systematic review, we reviewed the utility, attempts at validation, and application of such algorithms to detect nonmedical opioid use. Materials and Methods We searched PubMed and Embase for articles describing automatable algorithms that used electronic health care claims or records to identify patients or prescribers with likely nonmedical opioid use. We assessed algorithm development, validation, and performance characteristics and the settings where they were applied. Study variability precluded a meta-analysis. Results Of 15 included algorithms, 10 targeted patients, 2 targeted providers, 2 targeted both, and 1 identified medications with high abuse potential. Most patient-focused algorithms (67%) used prescription drug claims and/or medical claims, with diagnosis codes of substance abuse and/or dependence as the reference standard. Eleven algorithms were developed via regression modeling. Four used natural language processing, data mining, audit analysis, or factor analysis. Discussion Automated algorithms can facilitate population-level surveillance. However, there is no true gold standard for determining nonmedical opioid use. Users must recognize the implications of identifying false positives and, conversely, false negatives. Few algorithms have been applied in real-world settings. Conclusion Automated algorithms may facilitate identification of patients and/or providers most likely to need more intensive screening and/or intervention for nonmedical opioid use. Additional implementation research in real-world settings would clarify their utility.

[1]  Annesa Flentje,et al.  Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals. , 2014, Drug and alcohol dependence.

[2]  P. Buckley,et al.  Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study , 2012 .

[3]  S. Butler,et al.  Validation of a screener and opioid assessment measure for patients with chronic pain , 2004, Pain.

[4]  L. Webster,et al.  Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. , 2005, Pain medicine.

[5]  S. Butler,et al.  Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). , 2008, The journal of pain : official journal of the American Pain Society.

[6]  K. Miotto,et al.  Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. , 1998, Journal of pain and symptom management.

[7]  Kathleen Saunders,et al.  Automated prediction of risk for problem opioid use in a primary care setting. , 2015, The journal of pain : official journal of the American Pain Society.

[8]  J David Haddox,et al.  Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data. , 2004, The American journal of managed care.

[9]  Matt Schiller,et al.  A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. , 2012, Pain medicine.

[10]  Howard S. Smith,et al.  Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. , 2012, Pain physician.

[11]  David Cronkite,et al.  Using natural language processing to identify problem usage of prescription opioids , 2015, Int. J. Medical Informatics.

[12]  Scott Proescholdbell,et al.  The Use of a Prescription Drug Monitoring Program to Develop Algorithms to Identify Providers With Unusual Prescribing Practices for Controlled Substances , 2015, The Journal of Primary Prevention.

[13]  S. Butler,et al.  Development and validation of the Current Opioid Misuse Measure , 2007, PAIN.

[14]  Julie M Donohue,et al.  Defining Nonmedical Use of Prescription Opioids within Health Care Claims: A Systematic Review , 2015, Substance abuse.

[15]  Vijay S. Iyengar,et al.  Computer-aided auditing of prescription drug claims , 2014, Health care management science.

[16]  Mrinal Mugdh,et al.  A Decision Support Tool for Identifying Abuse of Controlled Substances by ForwardHealth Medicaid Members , 2010, Journal of hospital marketing & public relations.

[17]  Rose A Rudd,et al.  Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. , 2016, MMWR. Morbidity and mortality weekly report.

[18]  Matt Schiller,et al.  Analytic models to identify patients at risk for prescription opioid abuse. , 2009, The American journal of managed care.

[19]  J. Birt,et al.  Exploration of claims-based utilization measures for detecting potential nonmedical use of prescription drugs. , 2014, Journal of managed care & specialty pharmacy.

[20]  Kakoli Roy,et al.  Defining risk of prescription opioid overdose: pharmacy shopping and overlapping prescriptions among long-term opioid users in medicaid. , 2015, Journal of Pain.

[21]  H. Cabral,et al.  Refining Measurement of Substance Use Disorders Among Women of Child-Bearing Age Using Hospital Records: The Development of the Explicit-Mention Substance Abuse Need for Treatment in Women (EMSANT-W) Algorithm , 2015, Maternal and Child Health Journal.

[22]  B. Naliboff,et al.  Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance. , 2008, Journal of pain and symptom management.